6-Bromo-3-Hydroxypyrazine-2-Carboxamide CAS 259793-88-9 daahirnimo ≥99.0% Favipiravir Dhexdhexaad COVID-19

Sharaxaad Gaaban:

Magaca: 6-Bromo-3-Hydroxypyrazine-2-Carboxamide

CAS: 259793-88-9

Daahirsanaanta: ≥99.0%

Dhexdhexaadiyaha Favipiravir (CAS 259793-96-9) ee daaweynta caabuqyada fayraska hargabka iyo COVID-19

Tayada Sare, Wax Soo Saarka Ganacsiga

Inquiry: alvin@ruifuchem.com


Faahfaahinta Alaabta

Alaabooyinka La Xiriira

Tags Product

Sharaxaad:

Guryaha Kiimikada:

Magaca Kiimikada 6-Bromo-3-Hydroxypyrazine-2-Carboxamide
La mid ah Favipiravir Dhexdhexaad;Favipiravir wasakh 4
Lambarka CAS 259793-88-9
Lambarka CAT RF-PI296
Heerka Saamiyada Kaydka, Miisaanka Wax-soo-saarka Ilaa boqollaal Kiilogaram
Qaanuunka molecular C5H4BrN3O2
Miisaanka Molecular 218.01
Summada Kiimikada Ruifu

Tilmaamaha:

Shayga Tilmaamaha
Muuqashada Jaalle fudud ilaa budada Brown
Aqoonsiga IR, HPLC
Khasaare xagga qalajinta ≤1.0%
Hadhaaga dabka ≤0.20%
Xumaanta Keliya ≤0.50%
Wadarta wasakhda ≤1.0%
Biraha culus ≤20pm
Xalalka Haraaga ah La kulan faahfaahinta
Heerka Imtixaanka Heerka Ganacsiga
Isticmaalka Dhexdhexaadiyaha Favipiravir (CAS 259793-96-9)

Xidhmada & Kaydinta:

Xidhmada: Dhalo, boorsada aluminium aluminium, durbaanka kartoonada, 25kg/Drum, ama sida waafaqsan shuruudaha macmiilka.

Xaaladda Kaydinta:Ku kaydi weelasha xiran meel qabow oo qallalan;Ka ilaali iftiinka, qoyaanka iyo cayayaanka.

Faa'iidooyinka

1

FAQ:

Codsiga:

6-Bromo-3-Hydroxypyrazine-2-Carboxamide (CAS 259793-88-9) waa dhexdhexaad ah sida caadiga ah in synthesize of 6-Bromo-3-Hydroxypyrazine-2-Carboxamide ganacsi ahaan loo magacaabay Favipiravir (CAS 259793-96-9) daaweynta caabuqyada fayraska hargabka.Jid wax ku ool ah oo tallaabo-dhaqaale ah oo loo maro Favipiravir.Favipiravir waa badeeco cilmi-baariseed oo la xiriirta COVID19, oo lagu daweynayo bukaannada qaba COVID-19 oo ay ku talisay WHO.Favipiravir, oo sidoo kale loo yaqaan T-705 ama Avigan, waa daawada fayraska ka hortagga ah ee ay samaysay Toyama Chemical (Fujifilm Group) ee Japan oo leh dhaqdhaqaaq ka dhan ah fayrasyo ​​badan oo RNA ah.Favipiravir waxaa loo oggolaaday suuqgeynta Japan bishii Maarso 2014 waxaana loo adeegsaday daawaynta fayraska ee hargabka A iyo B. Marka laga soo tago fayraska hargabka, daawadu waxay sidoo kale muujisay firfircoonida fayraska fayraska ee noocyo kala duwan oo RNA ah, sida fayraska Ebola, fayraska ciidda. Feebarwari 2020 Favipiravir waxa lagu baranayey Shiinaha si tijaabo ah loogu daweeyo cudurka COVID-19 (Novel Coronavirus) ee degdega ah waxayna muujisay natiijooyin wanaagsan.

Halkan ku qor fariintaada oo noo soo dir